{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:19:27Z","timestamp":1790983167026,"version":"4.1.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.eimce.2026.503201","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:09:11Z","timestamp":1785701351000},"page":"503201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characterization of cutaneous mucormycosis in patients receiving Bruton tyrosine kinase inhibitor therapy with Ibrutinib: A new case report and comparative discussion"],"prefix":"10.1016","volume":"44","author":[{"given":"Borja","family":"Gonz\u00e1lez Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Arroyo Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Gotor Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"P\u00e9rez de Ayala Balzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Rodr\u00edguez Peralto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Postigo Llorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2026.503201_bib0085","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/jim-2016-000120.93","article-title":"Cutaneous mucormycosis in a patient with chronic lymphocytic leukemia: a pharmacological dilemma","volume":"64","author":"Castro","year":"2016","journal-title":"J Investigative Med"},{"key":"10.1016\/j.eimce.2026.503201_bib0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.14740\/wjon1099w","article-title":"Cutaneous mucormycosis following a bullous pemphigoid flare in a chronic lymphocytic leukemia patient on ibrutinib","volume":"9","author":"Stein","year":"2018","journal-title":"World J Oncol"},{"key":"10.1016\/j.eimce.2026.503201_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2021.e01132","article-title":"Post-traumatic cutaneous mucormycosis","volume":"24","author":"Hoesly","year":"2021","journal-title":"IDCases"},{"key":"10.1016\/j.eimce.2026.503201_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2021.e01120","article-title":"Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib","volume":"24","author":"Sittig","year":"2021","journal-title":"IDCases"},{"key":"10.1016\/j.eimce.2026.503201_bib0105","article-title":"Nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: early detection by metagenomic next-generation sequencing","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.eimce.2026.503201_bib0110","article-title":"Ibrutinib-associated cutaneous mucormycosis due to an Apophysomyces species: report of a case and review of the literature","volume":"11","author":"Nguyen","year":"2024","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.eimce.2026.503201_bib0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimce.2026.503201_bib0120","first-page":"194","article-title":"Global cutaneous mucormycosis: a systematic review","volume":"8","author":"Skiada","year":"2022","journal-title":"J Fungi (Basel, Switzerland)"},{"key":"10.1016\/j.eimce.2026.503201_bib0125","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.eimce.2026.503201_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100635","article-title":"Immunomodulatory effect of ibrutinib: reducing the barrier against fungal infections","volume":"40","author":"Maffei","year":"2020","journal-title":"Blood Rev"},{"key":"10.1016\/j.eimce.2026.503201_bib0135","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/jof7121058","article-title":"Invasive fungal infections and targeted therapies in hematological malignancies","volume":"7","author":"Little","year":"2021","journal-title":"J Fungi (Basel)"}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X26001188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X26001188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:09:26Z","timestamp":1785701366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X26001188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2529993X26001188"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2026.503201","relation":{},"ISSN":["2529-993X"],"issn-type":[{"value":"2529-993X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characterization of cutaneous mucormycosis in patients receiving Bruton tyrosine kinase inhibitor therapy with Ibrutinib: A new case report and comparative discussion","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2026.503201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"503201"}}